Exchange: NASDAQ·Updated 07:37 PM EDT
CALC logo

CALC CalciMedica Inc

$1.31
$0.03
(2.31%)
Today
Closed $1.27
$0.0392
(3.09%)
After Hours
Mkt Cap$8.88M
Vol82,148.00

About CALC

CalciMedica, Inc. is a clinical-stage biopharmaceutical company, which engages in developing therapies for life-threatening inflammatory diseases. The firm's product candidate, Auxora, helps in treating acute pancreatitis and asparaginase-associated pancreatitis. The company was founded by Kenneth A. Stauderman and Gonul Velicelebi in 2007 and is headquartered in La Jolla, CA.
52

Neutral Sentiment

How do you feel about CALC?

sh64
$CALC wtf r we heading to another split ? This management is crooks shit is keep going down offering after offering and no positive news only collecting money and robbing share holders. Fucking piss off 
1
3
MUBSN
$CALC Volatility Contraction Pattern... should end up with an explosion.... we are about to figure that out!!!! Best of luck for everyone. This should be the level to rebound from!!!
6
Super_Marioo
$CALC - down 10% but expecting at least a 100% gain soon. this is my top favorite ticker at the moment.
7
Super_Marioo
$CALC - unbelievable. we are green. I know it’s only 3.7% but most of my stocks are red today :)
6
pablo4
$CALC The filings today (8K and 424 (b)(5) prospectus) were necessary to link the "existing" ATM sales agreement dated August 11, 2023 to the newest shelf registration filed earlier this year in March. That is, to actually execute sales under the existing 2023 agreement using the new 2026 shelf registration, the company had to file a Prospectus Supplement (Form 424B5). The $25M ATM already existed long before today's filings...again, since 2023. However, that ATM could not be utilized after the March 2026 new shelf registration filing until a 424b5 prospectus was filed linking the ATM to the new shelf filing. In effect, the filings today, renew the effectiveness of a 3 year old ATM. That ATM wasn't utilized as far as I can tell after it was put in place. Whether the renewal of that ATM today is used, who knows? But I can't imagine and surely hope they don't consider it down here. I figure this was just protocol to have ready, if needed. Bad timing, though. JMO
6
pablo4
$CALC I'll still be traveling a while...but checking the board tonight. CALC has 2 more days to regain compliance. I'm not concerned in the slightest with the price not being sustained above a $1 close until compliance is regained. Once CALC announces it has regained compliance next week, I think we'll be ready to shift gears. Management could have done up to a 1 for 10 R/S but only did 1 for 5.....showing its confidence in the share price recovering and also a 1 for 5 being a sufficient split to assure regaining compliance with the 10 day above a buck rule. I still think shorts will have a much worse day(s) soon than longs have been experienced of late. I just hate I wasn't able to add shares today due to being on the road. JMO
6
pablo4
$CALC this is going to have a post-R/S surge to, conservatively, 5.50 to 7.50, IMO. I know it sounds excessive, sitting at the 2ish level. But, CALC isn't a flop bioscience and it has committed institutional investors as well as committed insider investors to prove it. Their recent additional investments at a cost of about double the current price says they see greater value than the 4s, for example....the price level where they went much deeper (that's a presplit adjusted price). Then, you have the minuscule float that makes the stock price vulnerable to great volatility when real volume pops up unexpectedly. Given the very depressed price, that volume will not cause a deep price descent but rather a tremendous price surge. Of course, all IMO.
6
mrtmermer80
$CALC Definitely not bored retail is dumping their shares, it isn’t getting shorted by retails. Short interest is low and flat around 140K shares. MM and funds that bought this stock is systematically creating selling pressure to grab more cheap shares in my opinion. Everything happening at low volume days. When volume came last week over 180K shares(not even a real volume) they barely stopped the momentum at $2.32. Who systematically sells their shares cheaper than what people wnats to pay. Patience will pay here. Seen this kimd of trading alot. I am not hopeful this week anymore but next week will be a new week.
5
mrtmermer80
$CALC Same f,,,,, trading. even I bring one million $ now, and buy as much as shares I can, tomorrow same seller will come and sell for less. It is impossible to beat someone wants to lose money with endless shares.
4
keokeostwiz
$CALC O/S count at 6.83M with 75% held by insiders 18.5 and institutions 57.5 with 3% short…float at 3.8M…..as grim as the current situation appears any positive news will lead to an instant recovery as so few shares available acknowledge that 39k at 1.37 listed this am…the science remains uniquely valuable supported with outstanding test results and insider confidence….time remains the outstanding issue as the overall equation is totally dependent on positive news……CALC will have a strong resurgence….when will that happen remains the mystery…JMO
3
sh64
$CALC .25 pre split even with a negative news won’t be this low this management put everyone at risk even themselves their average is .85 from June. 
2
66Caprice327
$CALC Interesting change in character over the last 24 hours. Repeated AH prints around $1.80 despite the stock trading near $1.65, followed today by an unusually hollow book with a 1.64–1.80 spread, concentrated bid support around $1.60 and relatively little displayed supply until $1.86–$1.90. Volume remains extremely thin, so this isn’t evidence of accumulation or a reversal…but it’s noticeably different from the persistent selling pressure we’ve been watching for the past month. Worth watching whether actual volume begins following the change in microstructure. As always…I know nothing. GL
4
Super_Marioo
$CALC - wow. down 26% as of today when I thought I had an excellent entry point at $2.25. STICKING with my strategy and will continue to hold.
4
66Caprice327
$CALC I’m in agreement with Pablo here. Not too concerned. I think the financing concern is reasonable, but I wouldn’t say it’s “very clear” that a funding issue is causing this drop. CALC reported $18.6M in cash at Q2 and guided its current operating plan as funded into 2H 2027, so there doesn’t appear to be an immediate need to raise at these prices. The bigger issue is that funding the AP Phase 2b would require additional capital. A partnership, warrant proceeds or another raise are all possibilities, but right now I think the market is pricing the uncertainty, amid low volume, not necessarily an imminent offering. Long and…
4
mrtmermer80
$CALC My question is how did they even convince SEC about Market Cap requirement. Not only they are going backwards about min SP requirement, their MC is at comical number. Moron management, how come you still dont have a deal for AP. Months and months passed . Crooks.
2
MUBSN
$CALC I think that dilution expectations are all priced in and that we have seen the floor. But never know... We should be ready to go up from these levels!
3
66Caprice327
$CALC These liquidity shocks are being followed by surprisingly aggressive absorption rather than sustained follow-through selling. I’d be more concerned if that wasn’t the case.
3
Profitone
$CALC What would need to happen to see significant value appreciation? • $5: funding secured + progress on AP/PAH. • $10: compelling clinical progress and reduced financial risk. • $20: positive PAH data + AP Phase 2b funded/underway. • $30: highly positive AP results and a clear path to registration/partnership. • $40: strong clinical evidence + strategic/commercial interest, driving valuation toward $276M or higher, depending on dilution.
3
keokeostwiz
$CALC Company continues silence approach while maintaining a consistent confidence behind the scene as time progresses toward year end a positive outlook forecast a price changing news event on the horizon…the question of when news will occur surrounds the present environment with uncertainty depressing the share price and exasperating investors…..with the value of the science and excellent test results secured….a positive momentum shift appears imminent…JMO
2
Robcat
$CALC Start a small position, today. Will add gradually little by little to ensure the possible lowest purchase cost. Happy Trade and Trade safe. Good luck.
2

Advertisement|Remove ads.